ArticleScientific reports2026
Revisiting bioluminescence and sucrose utilization in aquatic pathogens Vibrio harveyi and V. campbellii using genome-wide in silico mapping and phenotyping.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Vibrio harveyi is a major bacterial pathogen of shrimp and finfish aquaculture. Traditionally, bioluminescence and sucrose fermentation have served as key phenotypic marker for its identification. However, frequent misidentification with closely related species like V. campbellii necessitates a reassessment of these phenotypic traits. Therefore, these traits were evaluated for genomic distribution, targeted phenotypic validation and its potential role in evolution and speciation. We generated chromosome-level assemblies for seven strains, including V. harveyi SB1 reference genome, and performed genome-wide mapping of 282 strains (204 V. harveyi and 78 V. campbellii), followed by phenotypic validation of 49 isolates. In silico analysis revealed that only 2.9% of V. harveyi strains carry luminescence operon (luxCDABEGH), whereas 100% strains of V. campbellii carried either a functional luxCDABEGH (87.2%) or a defective luxBG operon (12.8%). The functional sucrose operon (scrRAKB) was present in 89.5% strains of V. harveyi (yellow colonies on TCBS agar) but was absent in all V. campbellii (green colony) except strain 170502. Mobilome and synteny analysis revealed horizontal gene transfer of scr operon in 1% strains, while no mobile genetic elements were associated with the luxCDABEGH operon in V. harveyi, despite rare occurrence. Core genome phylogeny indicated that V. harveyi represents an early-evolved lineage, whereas V. campbellii is a recently evolved species within the Harveyi clade. The evolutionary trajectory of V. campbellii further suggests that luminescence-defective strains (e.g., type strain CAIM519T) evolved alongside a group of strains carrying luminescence operon flanked by mobile-genetic elements (e.g., BAA-1116). Phenotypic assays and PCR screening of the luciferase gene (luxA) and sucrose uptake gene (scrA) results were consistent with the genomic findings. Collectively, the present study demonstrates that V. harveyi is predominantly non-luminescent and sucrose-fermenting (yellow), while V. campbellii is primarily luminescent and sucrose non-fermenting (green colonies), providing refined phenotypic criteria for their differential diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.